Filing Details
- Accession Number:
- 0001062993-22-023351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 18:05:45
- Reporting Period:
- 2022-12-02
- Accepted Time:
- 2022-12-05 18:05:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 748592 | Eterna Therapeutics Inc. | ERNA | Pharmaceutical Preparations (2834) | 311103425 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1234950 | D John Halpern | Po Box 540 Portsmouth NH 03802 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-02 | 335,920 | $3.28 | 450,961 | No | 4 | P | Indirect | As trustee of family trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | As trustee of family trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants (Right to Purchase) | Acquisiton | 2022-12-02 | 671,840 | $0.13 | 671,840 | $3.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 671,840 | 2023-06-02 | 2028-12-02 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 205 | Direct |
Footnotes
- Reflects a 1-for-20 reverse stock split effective October 17, 2022.
- Held by John D. Halpern
- Each share was purchased as part of a unit consisting of one share and two warrants, for a total purchase price of $3.53 per unit.
- The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.
Billionaire Hedge Funds
